rss
Br J Ophthalmol 2008;92:1577-1580 doi:10.1136/bjo.2008.149013
  • Editorial

Non-arteritic anterior ischaemic optic neuropathy and phosphodiesterase-5 inhibitors

  1. Sohan Singh Hayreh
  1. Professor S S Hayreh, Department of Ophthalmology and Visual Sciences, University of Iowa Hospitals & Clinics, 200 Hawkins Drive, Iowa City, IA 52242-1091, USA; sohan-hayreh{at}uiowa.edu

    Since 1998, phosphodiesterase type 5 (PDE5) inhibitors have been used extensively for the treatment of erectile dysfunction. These agents include sildenafil (Viagra, Pfizer), vardenafil (Levitra, Bayer AG) and tadalafil (Cialis, Lilly-ICOS LLC). Development of non-arteritic anterior ischaemic optic neuropathy (NA-AION) has been reported following the use of these drugs,1 mostly Viagra. I have discussed elsewhere the possible cause-and-effect relationship between the PDE5 inhibitors and NA-AION.1 To understand that relationship, it is absolutely essential that one must have an in-depth knowledge of the following related basic scientific facts:

    • blood supply of the optic nerve head: the factors that influence the ONH blood flow and its measurement;

    • pathogenesis of NA-AION;

    • systemic and ocular vascular effects of PDE5 inhibitors.

    Following is a brief discussion of these issues.

    BLOOD SUPPLY OF THE OPTIC NERVE HEAD (ONH): THE FACTORS THAT INFLUENCE THE ONH BLOOD FLOW AND ITS MEASUREMENT

    My multifaceted studies showed that posterior ciliary circulation is the main source of ONH blood supply.2 3 The blood flow in the ONH is influenced by many factors, discussed at length elsewhere.4 These include systemic arterial blood pressure, endothelial derived vasoactive agents, autoregulation of blood flow in the ONH and intraocular pressure. Autoregulation can be deranged by many systemic and local causes, including ageing, arterial hypertension, diabetes mellitus, marked arterial hypotension, arteriosclerosis, atherosclerosis, hypercholesterolaemia, vasospasm and probably regional vascular endothelial disorders.47 Many of those diseases also interfere with the release of endothelial derived vasoactive agents.4

    In spite of many claims, by using a variety of methods, unfortunately, we do not have as yet a reliable method of measuring blood flow in the ONH accurately;8 limitations of various advocated methods are discussed in detail elsewhere.8 There is a common misconception that since blood supply to the ONH is by the posterior ciliary artery circulation, measurements of blood flow in the short posterior ciliary arteries in the orbit …

    Register for free content

    The full back archive is now available for all BMJ Journals. Institutional subscribers may access the entire archive as part of their subscription. Personal subscribers will also have access to all content when logged in. Non-subscribers who register have free access to all articles published before 2006 right back to volume 1 issue 1. Register here to access the free archive of all BMJ Journals.

    Don't forget to sign up for content alerts so you keep up to date with all the articles as they are published.